Chunxia Su

Single-cell profiling of tumor heterogeneity and the microenvironment in advanced non-small cell lung cancer

Fengying Wu, Jue Fan, Yayi He et al. · Nature Communications · 2021 · 803 citations · Full text

Medicine, Cancer Biology, Oncology +15

Low-Dose Apatinib Optimizes Tumor Microenvironment and Potentiates Antitumor Effect of PD-1/PD-L1 Blockade in Lung Cancer

Sha Zhao, Shengxiang Ren, Tao Jiang et al. · Cancer Immunology Research · 2019 · 334 citations

Medicine, Oncology, Pharmacology +17

Continuous inertial cavitation evokes massive ROS for reinforcing sonodynamic therapy and immunogenic cell death against breast carcinoma

Yifei Yin, Xingwu Jiang, Liping Sun et al. · Nano Today · 2020 · 214 citations

Medicine, Immunology, Oncology +9

Icotinib versus chemotherapy as adjuvant treatment for stage II–IIIA EGFR-mutant non-small-cell lung cancer (EVIDENCE): a randomised, open-label, phase 3 trial

Jianxing He, Chunxia Su, Wenhua Liang et al. · The Lancet Respiratory Medicine · 2021 · 184 citations

Medicine, Oncology, Pharmacology +13

MiR-21 overexpression is associated with acquired resistance of EGFR-TKI in non-small cell lung cancer

Bing Li, Shengxiang Ren, Xuefei Li et al. · Lung Cancer · 2013 · 178 citations

Medicine, Molecular Biology, Oncology +14